参考文献/References:
[1] He L,Liu F,Huang GY,et al.Application of selective coronary angiography in children with Kawasaki disease complicated with severe coronary artery lesion[J].Chin J Pediatr,2019,57(2):108-112.
[2] Jakob A,Schachinger E,Klau S,et al.Von willebrand factor parameters as potential biomarkers for disease activity and coronary artery lesion in patients with Kawasaki disease[J].Eur J Pediatr,2020,179(3):377-384.
[3] 邢 前.血清白蛋白、血小板反应蛋白1及血小板反应蛋白2水平对川崎病患儿发生静脉注射免疫球蛋白抵抗的预测价值[J].广西医学,2019,41(16):2059-2062.
[4] 刘慧兰,李晓宁,付 帅,等.血清胱抑素C对急性冠脉综合征患者急性肾损伤发病和预后的预测价值[J].临床肾脏病杂志,2019,19(7):482-487.
[5] 杨艳章,王 莉,杨艳芳,等.川崎病患儿并发冠状动脉病变相关危险因素与治疗分析[J].中国妇幼保健,2019,34(14):3244-3246.
[6] 中华医学会儿科学分会心血管学组,中华儿科杂志编辑委员会.川崎病冠状动脉病变的临床处理建议(2020年修订版)[J].中华儿科杂志,2020,58(9):718-724.
[7] 刘 静,马金海,蒋立夏.Kobayashi、Harada两种评分体系预测川崎病冠状动脉损害的价值分析[J].中国妇幼保健,2019,34(24):5704-5707.
[8] Maccora I,Calabri GB,Favilli S,et al.Long-term follow-up of coronary artery lesions in children in Kawasaki syndrome[J].Eur J Pediatr,2021,180(1):271-275.
[9] Duan J,Jiang H,Lu M.Risk factors for coronary artery lesions in children with Kawasaki disease[J].Arch Argent Pediatr,2020,118(5):327-331.
[10] 李 垚,陈万林,杨 平,等.与冠心病患者冠状动脉病变及叶酸水平相关性研究[J].陕西医学杂志,2021,50(1):22-25.
[11] 龚 华,林 辉,刘 伟,等.术后早期肠内免疫营养对大肠癌患者营养状态、免疫功能和炎症反应的影响[J].陕西医学杂志,2019,48(5):575-577,580.
[12] 马红玲,宁立芬.血清C反应蛋白、B型脑钠肽、降钙素原和前白蛋白检测对小儿急性呼吸道感染病情诊断和疗效评估的价值[J].川北医学院学报,2020,35(1):52-56.
[13] 钟凯丽.胱抑素C、血肌酐联合尿肌酐、尿素氮检测对代谢综合征患者早期肾损害的诊断价值[J].检验医学与临床,2019,16(21):3204-3207.
[14] 庞连胜,赵万春.血清CysC、尿β2-MG、尿mAlb三项联合检测对肝癌及肝硬化继发早期肾功能损伤的诊断价值[J].肝脏,2019,24(6):649-652.
[15] 朱小川.血小板/淋巴细胞比值预测慢性阻塞性肺疾病急性加重期伴有早期肾功能损害临床价值[J].陕西医学杂志,2019,48(10):1352-1354,1392.
[16] 朱再富,范晓晨.川崎病患儿红细胞分布宽度变化及意义[J].临床儿科杂志,2020,38(3):182-185.
[17] 刘 倩,范晓晨.血浆前清蛋白对川崎病患儿冠状动脉病变的预测意义[J].安徽医学,2020,41(4):389-392.
[18] 王 建,刘晓红,陈若诗,等.血清胱抑素C与常见心血管疾病的关系[J].中国介入心脏病学杂志,2020,28(10):585-588.
[19] 吴 凡,汤卫红,叶 姗,等.川崎病急性期血清胱抑素C水平与冠脉病变的关系[J].中国妇幼健康研究,2020,31(6):717-721.
[20] 赖雪芹,赵 青,郭健秋,等.N端前脑钠肽与原田危险评分、小林评分对川崎病病儿冠状动脉病变风险预测价值的对比[J].安徽医药,2020,24(4):688-691.
相似文献/References:
[1]穆志龙,高 颖△,卫 丽,等.热休克蛋白60、70在川崎病冠状动脉病变中的表达及意义*[J].陕西医学杂志,2020,49(9):1117.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.016]
MU Zhilong,GAO Ying,WEI Li,et al.Expression and significance of HSP60 and HSP70 in coronary artery disease of Kawasaki disease[J].,2020,49(12):1117.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.016]
[2]杨荣荣,马佳娜△.超声心动图和心肌酶学检测在患儿川崎病合并冠状动脉病变诊断中的应用*[J].陕西医学杂志,2020,49(10):1259.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.015]
YANG Rongrong,MA Jiana..Application value analysis of echocardiography and myocardial enzyme indexes in children with Kawasaki disease complicated with coronary artery disease[J].,2020,49(12):1259.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.015]
[3]李佳娜,艾世宜,李 星.老年高血压合并冠心病患者血压晨峰与血清可溶性血管黏附因子1和干扰素γ相关性分析[J].陕西医学杂志,2021,50(7):825.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.014]
LI Jia'na,AI Shiyi,LI Xing.Correlation between morning peak of blood pressure and serum sVCAM-1 and IFN-γ in elderly patients with hypertension and coronary heart disease[J].,2021,50(12):825.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.014]
[4]严晓华,王 娜,马 娟,等.阿托伐他汀对小鼠川崎病的治疗作用及机制研究[J].陕西医学杂志,2022,51(6):672.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.007]
YAN Xiaohua,WANG Na,MA Juan,et al.Therapeutic effect and mechanism of atorvastatin on Kawasaki disease mice[J].,2022,51(12):672.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.007]
[5]寇志军,李 静,马亨曼,等.川崎病患儿心血管病变易感性与血清N末端B型脑钠肽原、前白蛋白及C-反应蛋白表达水平相关性研究[J].陕西医学杂志,2022,51(6):717.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.018]
KOU Zhijun,LI Jing,MA Hengman,et al.Correlation between cardiovascular disease susceptibility and serum levels of NT-proBNP,PA and CRP in children with Kawasaki disease[J].,2022,51(12):717.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.018]
[6]张凤梅,蔡 颖,吴 迪,等.多不饱和脂肪酸ω-3/多不饱和脂肪酸ω-6与冠状动脉病变相关性研究[J].陕西医学杂志,2023,52(10):1326.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.009]
ZHANG Fengmei,CAI Ying,WU Di,et al.Research on correlation of ω-3,ω-6 and their ratio with coronary artery disease[J].,2023,52(12):1326.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.009]
[7]赵 萌,杨轶童,李翰文,等.肠道微生物菌群与川崎病关系研究进展[J].陕西医学杂志,2024,(2):270.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.027]
ZHAO Meng,YANG Yitong,LI Hanwen,et al.Research progress on relationship between gut microbiota and Kawasaki disease[J].,2024,(12):270.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.027]
[8]贾臣英,李建丽,袁帅朋,等.英国前瞻性糖尿病研究评分联合下肢动脉病变分级对2型糖尿病患者冠状动脉病变程度的预测价值[J].陕西医学杂志,2024,(9):1193.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.008]
JIA Chenying,LI Jianli,YUAN Shuaipeng,et al.Predictive value of UKPDS score combined with lower extremity arterial disease classification in coronary artery lesion degree of T2DM patients[J].,2024,(12):1193.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.008]
[9]耿 鹃,周 耀,刘旭辉.微小RNA-492、红细胞微粒水平与ST段抬高型急性心肌梗死患者冠状动脉病变严重程度关系研究[J].陕西医学杂志,2024,(9):1249.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.021]
GENG Juan,ZHOU Yao,LIU Xuhui.Relationship between level of miR-492,erythrocyte microparticles and severity of coronary artery lesions in STEMI patients[J].,2024,(12):1249.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.021]
[10]冷 俊,郁 淼,秦 兵,等.血清可溶性生长刺激表达基因2蛋白、胱抑素C、C反应蛋白与冠状动脉病变严重程度的相关性及预后影响因素分析[J].陕西医学杂志,2025,54(1):114.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.023]
LENG Jun,YU Miao,QIN Bing,et al.Correlation between serum sST2,CysC,CRP and severity of coronary artery disease and prognostic factors[J].,2025,54(12):114.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.023]
[11]冯千伟,王晓青,焦丽华,等.川崎病患儿血清血管生成素样蛋白8、生长分化因子-15水平与并发冠状动脉病变关系研究[J].陕西医学杂志,2025,54(3):364.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.015]
FENG Qianwei,WANG Xiaoqing,JIAO Lihua,et al.Relationship between serum ANGPTL8,GDF-15 levels with concurrent coronary artery disease in children with Kawasaki disease[J].,2025,54(12):364.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.015]